Effect of a Home-Based Wearable Continuous ECG Monitoring Patch on Detection of Undiagnosed Atrial Fibrillation: 
The mSToPS Randomized Clinical Trial

Steven R. Steinhubl, MD; Jill Waalen, MD, MPH; Alison M. Edwards, MStat; Lauren M. Ariniello, BS; Rajesh R. Mehta, RPh, MS; Gail S. Ebner, BS; Chureen Carter, PharmD, MS; Katie Baca-Motes, MBA; Elise Felicione, MPH, MBA; Troy Sarich, PhD; Eric J. Topol, MD

The mobile health Screening To Prevent Strokes (mSToPS) trial investigated whether or not it is possible to identify a high-risk cohort suitable for targeted detection for asymptomatic atrial fibrillation.

Participants in the study were engaged in a mobile-health-technology-enabled monitoring program to document previously undiagnosed AF and provide clinical evidence of an outcomes benefit associated with early detection.1

As published in JAMA.